|
Wednesday, September 16, 2026
|
||
|
65° |
Sep 16's Weather Clouds HI: 67 LOW: 63 Full Forecast (powered by OpenWeather) |
Free Daily Headlines
Charles George VA Medical Center will participate in a new clinical trial to evaluate the efficacy of semaglutide, a GLP-1 receptor agonist used to treat diabetes, as treatment for alcohol use disorder, the VA hospital announced last week.
Non-subscribers may read two (2) stories every 30 days for free. To continue reading, please log in or subscribe for only $59.99 per year.